Please login to the form below

Not currently logged in

EMA develops framework for academia collaborations

Looks to develop the way it works with the academic community


The European Medicines Agency (EMA) has developed a three-year plan to structure and further develop its interactions with the academic community.

The regulator wants to increase trust with its systems by promoting awareness, supporting academic research and improving communications.

Guido Rasi, EMA’s executive director, said: “The framework will allow us to integrate cutting-edge scientific knowledge more tightly into our activities.

“It will also help academic start-ups benefit from advice from the EU regulatory network to translate their discoveries into patient-focus medicines.”

The framework builds on EMA’s experience in working with stakeholder associations representing patients and consumers, healthcare professionals and the pharmaceutical industry.

Professor Piet van der Graaf, Leiden Academic Centre for Drug Research (LACDR), said: “This is an important step towards a strong alignment of the European excellence in regulatory and academic pharmaceutical sciences.

“In my discipline of systems pharmacology, I expect that this will act as a catalyst for new and better collaborations and cross-fertilisation in research, training and education.”

In addition the EMA has developed an action plan which includes initiatives for mutual education and training, staff exchange programmes, a strategic research agenda for regulatory science.

The agency has also created a new section on its website to provide information for academia, including details of its work in personalised medicine, big data, adaptive pathways and patient registries.

Commenting on the EMA’s framework, Dr Rosa Giuliani from the European Society for Medical Oncology’s (ESMO) EU policy committee said: “The dialogue between EMA and academia has already improved in time. However, this is the perfect moment to structure this interaction and bring it to the next level.

“The framework of collaboration is a timely initiative, which is expected to fulfil specific tasks. This is the platform needed to 1) promote regulatory awareness, 2) support academic research and 3) boost communication between the two parties. Now it is time to work!”

Article by
Gemma Jones

27th April 2017

From: Marketing



Featured jobs

Subscribe to our email news alerts


Add my company
M&F Health

M&F Health is a full service communications agency, dedicated to the health and wellbeing sector. We are an independent amongst...

Latest intelligence

Digital health
The untapped potential to transform healthcare...
When is it time to rebrand?
The Biosimilar Challenge